Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 9,412

Document Document Title
WO/2013/172714A1
We describe a composition comprising a non-digestible oligosaccharide for the treatment, prevention or alleviation of a trichothecene mycotoxin exposure associated condition. The non-digestible oligosaccharide may comprise a galactooligo...  
WO/2013/169740A2
Synthetic triterpenoids and methods of using the same to induce gene expression and differentiation of stem or progenitor cells are provided.  
WO/2013/155720A1
A fatigue relief and health care capsule, the capsule being prepared from ganoderma lucidum extract, pseudostellaria root extract, codonopsis pilosula extract, wolfberry fruit extract, and hericium erinaceus extract.  
WO/2013/155717A1
Provided is a body building capsule, comprising Ganoderma lucidum extract, Radix Panacis Quinquefolii extract, milkvetch root extract, Hericium erinaceus extract and Paecilomyces hepialid mycelium.  
WO/2013/149333A1
The present invention relates to food-grade bacteria and methods for removing toxic compounds, including lead, cadmium, mercury, arsenic and pesticides, from contaminated environments or substances.  
WO/2013/152055A1
Radiation - oxidative exposure treatment compositions comprise a mixture of micronutrient multivitamin and trace elements, a mixture of antioxidants and chemopreventative agents, and optionally a mixture of fatty acids. Micronutrient mul...  
WO/2013/148183A2  
WO/2013/143322A1
The present invention relates to the technical field of medicine, and relates specifically to a method for dissolving a flavonoid compound, a carbon glycoside compound, or a stilbene compound and a method for preparing an injection or a ...  
WO/2013/147439A1
The present invention relates to a systemic immunity or gut immunity adjuvant comprising ethanol-soluble cheonggukjang extracts as active ingredients. The immunity adjuvant comprising ethanol-soluble cheonggukjang extracts according to t...  
WO/2013/141759A3
The invention relates to medicine, specifically to neurology and cardiology, namely to the production of a drug in the form of a biologically active nanopreparation having antihypoxic and antioxidant activity. The use of liposomal con...  
WO/2013/142258A1
The present disclosure is directed to compositions comprising encapsulated particles of diethylenetriaminepentaacetate (DTPA) and a zinc salt such as zinc acetate, and to pharmaceutical compositions comprising such encapsulated compositi...  
WO/2013/137777A1
The invention relates to the field of the pharmaceutical industry and medicine. The problem addressed by the present invention is that of producing an effective pharmaceutical composition having neuroprotector, antiamnesic, antioxidan...  
WO/2013/137844A1
A method for isolating flavonoid Dihydroquercetin (taxifolin) from wood parts including lower portions of the trunk, referred to as butt logs, bark and roots. The method includes extracting either the particle-reduced chip fraction obtai...  
WO/2013/137854A1
Antibodies and antibody fragments that selectively bind to nanoparticles are provided herein.  
WO/2013/137778A1
The invention relates to the field of the pharmaceutical industry and medicine, and can be used in the production and use of solid dosage forms having neuroprotector, antiamnesic, antioxidant, antihypoxic and antiischaemic activity. T...  
WO/2013/127146A1
Provided is a Lactobacillus plantarum able to relieve lead toxicity and the use thereof. The Lactobacillus plantarum is Lactobacillus plantarum CCFM8661, which has good acid tolerance and good tolerance to lead ions in vitro. The Lactoba...  
WO/2013/129977A3
The invention relates to the field of the pharmaceutical industry and medicine. The problem of the invention consists in producing a pharmaceutical composition having neuroprotector, antiamnaesic, antioxidant, antihypoxic and antiischaem...  
WO/2013/129960A1
The invention relates to the field of medicine and concerns a pharmaceutical composition in which the treatment effect is produced as a result of the action of the antioxidant, antimicrobial and antitoxic human lactoferrin protein and wh...  
WO/2013/125135A1
Provided is an anthocyanin-containing composition which enhances the bioabsorbability of anthocyanins, which have low bioavailability, causes anthocyanins to be more effectively absorbed in vivo, and enhances absorption of anthocyanins i...  
WO/2013/123618A1
A process for the manufacture of an extract of the skin of Goji berries containing zeaxanthin and/or its esters, comprises the following steps: a) obtaining dried skin of Goji berries or the size reduced pieces thereof; and b) extracting...  
WO/2013/120379A1
Provided in the present invention is the use of SBT in the preparation of an inhibitor of GSK-3β, and in particular in the preparation of medicines for preventing and treating Alzheimer's disease and senescence.  
WO/2013/122501A1
The invention concerns a pharmaceutical composition for the treatment of acute toxic conditions and relates to the field of medicine, more particularly nanotechnology and toxicology, and can be used for the prevention and treatment of to...  
WO/2013/120081A1
The present disclosure provides biologically active compounds of formula (I): and pharmaceutically acceptable salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such...  
WO/2013/111801A1
Provided is a triblock copolymer represented by general formula (I): CNR-PEG-CNR (wherein CNR's independently represent a polymer segment that contains a repeating unit containing, as a part of a pendant group, a cyclic nitroxide radical...  
WO/2013/108822A1
Provided are food and drink, a non-medicinal product, and a medicine in which high antioxidant effect is exhibited over a long period of time in vivo. Des(rhamnosyl) acteoside is added to an olive extract, whereby high antioxidant activi...  
WO/2013/107236A1
Disclosed is a crystal form of (6S)-5- methyltetrahydrofolate salt and a method for preparing same. The crystal form is: C form of the crystal form of (6S)-5- methyltetrahydrofolate calcium salt, the X-ray diffraction pattern thereof hav...  
WO/2013/106683A1
The present disclosure provides methods of treating and/or preventing cancer in a subject comprising administering to the subject a copper-reduced diet by itself or as a supplement along with a regular diet to create a copper-reduced mel...  
WO/2013/097274A1
An active small-molecule donkey-hide gelatin mixture and a preparation method and application thereof. The active small-molecule donkey-hide gelatin mixture is prepared by using the compound protease comprising the proline protease to pe...  
WO/2013/099883A1
Disclosed are: a lactic acid bacterium which has a higher IgA production promoting activity than that of Lactobacillus strain GG (ATCC53103) and a lower mitogenic activity and a lower IL-2 production promoting activity than those of List...  
WO/2013/083552A1
The invention describes diphenylhydramine (DPH) for treating ototoxicity in a subject, for inhibiting the formation of platinum adducts in a cell of the inner ear, and for preventing and/or inhibiting structural and functional damage in ...  
WO/2013/079394A1
The present invention generally relates to the field of nutrition, health and wellness. For example, the present invention relates to hydroxycinnamic acids and their health benefits. The present invention discloses compositions that allo...  
WO/2013/075391A1
Disclosed are an electromagnetic therapeutic apparatus and a supporting physiotherapy liquid thereof, wherein upper magnetic heads (13) are mounted on the frame of the electromagnetic therapeutic apparatus via a bearing and lower magneti...  
WO/2013/073577A1
[Problem] To provide a compound which has a D-amino acid oxidase (DAAO) inhibitory effect and is useful, for example, as a prophylactic and/or therapeutic agent for schizophrenia and neuropathic pain. [Solution] The inventors have achiev...  
WO/2013/071400A8
The present application relates to novel apocynin-lipoic acid covalent conjugates, compositions comprising these compounds and their use, in particular for the treatment of diseases, disorders or conditions that are mediated by oxidative...  
WO/2013/071400A1
The present application relates to novel apocynin-lopioc acid covalent conjugates, compositions comprising these compounds and their use, in particular for the treatment of diseases, disorders or conditions that are mediated by oxidative...  
WO/2013/072441A1
The present invention relates to a composition consisting of Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin. The present invention relates further to the use of the comp...  
WO/2013/066398A1
In some embodiments, the present invention provides methods of treating oxidative stress in a subject by administering a therapeutic composition to the subject. In some embodiments, the therapeutic composition comprises a carbon nanomate...  
WO/2013/063889A1
Provided is the use of multiflora glycoside in preparing an anti-hypoxic drug. A full body and cell level hypoxia model indicates that multiflora glycoside can significantly increase the survival time of a mouse with asphyxiant hypoxia, ...  
WO/2013/061724A1
Provided are a novel radical inhibitor, a composition containing the same, and a radical generation inhibition method using the same. This radical inhibitor comprises a salen complex compound of a divalent metal.  
WO/2013/059651A1
A compound having the formula (I) wherein X is S, SO or SO2; one of R1, R2, and R3 is O and the others of R1, R2 and R3 are independently, the same or different, CH2, or CR13 wherein, R13 is an alkyl group, an alkenyl group, an alkynyl g...  
WO/2013/057675A1
The present invention relates to an alkenylglucosinolate composition which under stomach conditions generates the corresponding epithionitrile derivative, which has detoxifying properties. It also relates to a food composition containing...  
WO/2013/055385A3
The invention generally relates to methods of treating a patient having, and/or at risk of, oxidative distress disorders and/or age-related disorders. The disclosure also generally relates to methods of treating memory impairment or enha...  
WO/2013/055385A2
The invention generally relates to methods of treating a patient having, and/or at risk of, oxidative distress disorders and/or age-related disorders. The disclosure also generally relates to methods of treating memory impairment or enha...  
WO/2013/051680A1
The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or...  
WO/2013/051389A1
Provided are: a medicinal agent responsive to a metal salen complex compound, which can neutralize the cytotoxity of the metal salen complex compound and has a detoxifying activity; and a system for controlling the in vivo behavior of a ...  
WO/2013/047082A1
The present invention addresses the problem of providing a means for efficiently degrading an exogenous opioid peptide. Provided is an exogenous opioid peptide-degrading enzyme comprising one or more components selected from the group co...  
WO/2013/049519A2
The present invention relates to compositions, kits and methods for the administration of compositions and kits for supplementation with twelve carbon chain fatty acids or twelve carbon chain acylglycerols; and specifically for the suppl...  
WO/2013/043085A8
The invention relates to various fields of medicine, pharmaceutics and pharmacology and the chemical pharmaceutical, pharmaceutical and parapharmaceutical industry, and specifically concerns a novel class of agents which exhibit modulato...  
WO/2013/042065A4
The invention provides compounds which are inhibitor of ricin, abrin, Shiga or saporin and which have a bipartite configuration comprising an aromatic heterocyclic structure resembling an adenine moiety in size and shape connected at the...  
WO/2013/042065A3
The invention provides compounds which are inhibitor of ricin, abrin, Shiga or saporin and which have a bipartite configuration comprising an aromatic heterocyclic structure resembling an adenine moiety in size and shape connected at the...  

Matches 101 - 150 out of 9,412